Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IPT
|
|||
| Drug Name |
AGS-v
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 1 | [1] | |
| Company |
ImutexLondon, United Kingdom National Institute of Allergy and Infectious Diseases Bethesda, MD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.